[(1R)-1-(Dimethylamino)ethyl]ferrocene
[CAS# 31886-58-5]

Identification

• Classification: Organic raw materials >> Organometallic compound >> Organic iron
• Name: [(1R)-1-(Dimethylamino)ethyl]ferrocene
• Synonyms: (R)-(+)-N,N-Dimethyl-1-ferrocenylethylamine
• Molecular Formula: C₁₄H₁₉FeN
• Molecular Weight: 257.15
• CAS Registry Number: 31886-58-5
• EC Number: 621-376-8
• SMILES: C[C@H]([c-]1cccc1)N(C)C.[cH-]1cccc1.[Fe+2]

Safety Data

• Hazard Symbols: GHS07 Warning
• Hazard Statements: H315-H319
• Precautionary Statements: P305+P351+P338

Hazard Classification

Hazard	Class	Category Code	Hazard Statement
Eye irritation	Eye Irrit.	2	H319
Skin irritation	Skin Irrit.	2	H315
Skin corrosion	Skin Corr.	1	H314
Acute toxicity	Acute Tox.	3	H311
Acute toxicity	Acute Tox.	3	H331
Serious eye damage	Eye Dam.	1	H318
Acute toxicity	Acute Tox.	3	H301
Chronic hazardous to the aquatic environment	Aquatic Chronic	2	H411

Discovory and Applicatios

[(1R)-1-(Dimethylamino)ethyl]ferrocene is an organometallic compound that integrates a ferrocene core with a chiral dimethylaminoethyl substituent. This compound exemplifies the intersection of organometallic chemistry and chiral synthesis, contributing to both fundamental research and practical applications in various fields.

The discovery of [(1R)-1-(Dimethylamino)ethyl]ferrocene stems from the exploration of functionalized ferrocene derivatives, which are widely recognized for their unique electronic properties and catalytic potential. Ferrocene, an archetypal metallocene, consists of an iron atom sandwiched between two cyclopentadienyl rings. The incorporation of the dimethylaminoethyl group, specifically in the (1R)-configuration, was pursued to leverage chirality for enhanced selectivity and reactivity in chemical processes.

The synthesis of [(1R)-1-(Dimethylamino)ethyl]ferrocene involves several key steps. Initially, the synthesis begins with the preparation of the chiral dimethylaminoethyl substituent. This typically involves a resolution process to obtain the (1R)-enantiomer, which is then introduced to the ferrocene core. The coupling reaction is usually carried out using alkylation techniques where ferrocene is reacted with the chiral dimethylaminoethyl reagent. The product is purified using standard methods such as column chromatography or recrystallization to ensure high purity and yield.

One of the prominent applications of [(1R)-1-(Dimethylamino)ethyl]ferrocene is in asymmetric catalysis. The chiral nature of the dimethylaminoethyl group enhances the compound's ability to induce chirality in catalytic reactions. This property is particularly valuable in asymmetric synthesis, where the generation of enantiomerically pure compounds is crucial. The compound has been employed as a chiral ligand in various transition metal-catalyzed reactions, including asymmetric hydrogenation and enantioselective alkylation. The (1R)-configuration of the substituent ensures high levels of chirality transfer, leading to improved selectivity and yield in these reactions.

In addition to its role in asymmetric catalysis, [(1R)-1-(Dimethylamino)ethyl]ferrocene is utilized in materials science for its ability to modify the electronic properties of ferrocene-based materials. The presence of the chiral dimethylaminoethyl group can influence the electronic and optical characteristics of the material, making it suitable for applications in organic electronics and sensors. For example, the compound has been used in the development of chiral organic semiconductors and optoelectronic devices, where its unique properties contribute to enhanced performance and functionality.

Another area of application is in medicinal chemistry, where the chiral nature of [(1R)-1-(Dimethylamino)ethyl]ferrocene is explored for potential therapeutic uses. The ferrocene moiety, known for its potential bioactivity, combined with the chiral dimethylaminoethyl group, may lead to compounds with novel biological activities. Research into the bioactivity of such compounds could open new avenues for drug development or provide insights into the design of chiral pharmaceuticals.

The advantages of [(1R)-1-(Dimethylamino)ethyl]ferrocene include its chiral functionality, which enhances its utility in asymmetric catalysis and materials science. However, challenges include optimizing the synthesis for better yields and exploring the full range of its applications. Future research may focus on improving the efficiency of its synthesis, expanding its applications in various fields, and further investigating its biological activities.

Continued study of [(1R)-1-(Dimethylamino)ethyl]ferrocene promises to advance both fundamental understanding and practical applications of chiral organometallic compounds. Its unique properties offer potential benefits in catalysis, materials science, and medicinal chemistry, contributing to advancements in these areas.